Security key
74638P109
PURPLE BIOTECH LTD SPONSORED ADR - ADR (PPBT)
CUSIP: 74638P109
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / ADR
- Total 13F shares
- 579,660
- Total 13F value
- $2,393,000
- Share change
- -535,647
- SEC-reported price per share
- $4.13
- Number of holders
- 13
- Value change
- -$2,187,977
- Number of buys
- 7
- Number of sells
- 11
Report period
Q1 2021
Institutions
13
Top holders
10
PPBT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
PURPLE BIOTECH LTD. SEC filings
PURPLE BIOTECH LTD. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74638P109
Recent filing periods:
Ownership snapshot
Top reported holders of PPBT - PURPLE BIOTECH LTD SPONSORED ADR - ADR (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F
Highest disclosed value: $1,885,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
MORGAN STANLEY has the largest disclosed position value at $1.88M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MORGAN STANLEY's linked filing trail.
Disclosed position value
Top 5
MORGAN STANLEY
$1.88M
ORBIMED ADVISORS LLC
$1.32M
RENAISSANCE TECHNOLOGIES LLC
$491K
SUSQUEHANNA FUNDAMENTAL INVESTMEN...
$110K
GOLDMAN SACHS GROUP INC
$100K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$1,885,000
494,715 shares
|
— | 31 Dec 2020 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$1,319,000
346,197 shares
|
— | 31 Dec 2020 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$491,000
128,900 shares
|
— | 31 Dec 2020 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
Company
|
—
denominator unverified
|
$110,000
28,800 shares
|
— | 31 Dec 2020 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
—
denominator unverified
|
$100,000
26,167 shares
|
— | 31 Dec 2020 |
| Virtu Financial LLC |
13F
Company
|
—
denominator unverified
|
$88,000
22,988 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
579,660
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q4 2025 Across Filers
Q4 2025 holders
1
Q1 2021 holders
13
Holder diff
12
| Investor | Q4 2025 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend